News
THE 41 st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) opened its doors in Paris, ...
Rabin Medical Center researcher says current standard for testing hereditary disease risk doesn’t account for Jews and other ...
Myriad Genetics, Inc. (NASDAQ:MYGN) is one of the Best 52-Week Low Penny Stocks to Buy Now. On August 5, Daniel Brennan from ...
Professor Idit Maya said the discovery has ‘significant implications, especially for Jews in Israel and the Diaspora’ ...
Spinal muscular atrophy (SMA) is a genetic neuromuscular disease affecting specialized nerve cells that control voluntary ...
MONDAY, Aug. 11, 2025 (HealthDay News) — Spinal muscular atrophy (SMA) is a genetic neuromuscular disease affecting ...
Overview of the MarketThe global Prenatal Genetic Testing Market is valued at USD 7.01 billion in 2024 and is projected to ...
Fetal Focus uses non-invasive prenatal testing to detect key genetic conditions without needing the father’s DNA, keeping ...
As intentional motherhood becomes the norm, a new demographic shift is quietly reshaping maternal care, fertility ...
Natera, Inc. (NASDAQ:NTRA) is one of the 14 Best Aggressive Growth Stocks to Buy According to Analysts. On July 28, Evercore ...
Shares of genetic testing company Natera (NASDAQ:NTRA) jumped sharply in morning trading, rising as much as 17% after the ...
Genetic testing company Natera (NASDAQ:NTRA). reported Q2 CY2025 results topping the market’s revenue expectations, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results